Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rifaximin treatment in hepatic encephalopathy.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Bass NM, et al. Among authors: mullen kd. N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893. N Engl J Med. 2010. PMID: 20335583 Free article. Clinical Trial.
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
Sanyal A, Younossi ZM, Bass NM, Mullen KD, Poordad F, Brown RS, Vemuru RP, Mazen Jamal M, Huang S, Merchant K, Bortey E, Forbes WP. Sanyal A, et al. Among authors: mullen kd. Aliment Pharmacol Ther. 2011 Oct;34(8):853-61. doi: 10.1111/j.1365-2036.2011.04808.x. Epub 2011 Aug 17. Aliment Pharmacol Ther. 2011. PMID: 21848797 Free article. Clinical Trial.
Rifaximin has the potential to prevent complications of cirrhosis.
Flamm SL, Mullen KD, Heimanson Z, Sanyal AJ. Flamm SL, et al. Among authors: mullen kd. Therap Adv Gastroenterol. 2018 Sep 28;11:1756284818800307. doi: 10.1177/1756284818800307. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30283499 Free PMC article.
Optimal treatment of hepatic encephalopathy.
Waghray A, Waghray N, Kanna S, Mullen K. Waghray A, et al. Minerva Gastroenterol Dietol. 2014 Mar;60(1):55-70. Minerva Gastroenterol Dietol. 2014. PMID: 24632768 Review.
Mechanisms, diagnosis and management of hepatic encephalopathy.
Prakash R, Mullen KD. Prakash R, et al. Among authors: mullen kd. Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):515-25. doi: 10.1038/nrgastro.2010.116. Epub 2010 Aug 10. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20703237 Review.
New perspectives in hepatic encephalopathy.
Mullen KD, Prakash RK. Mullen KD, et al. Clin Liver Dis. 2012 Feb;16(1):1-5. doi: 10.1016/j.cld.2012.01.001. Epub 2012 Jan 16. Clin Liver Dis. 2012. PMID: 22321461 Review.
161 results